Clinical Trial Update: Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ketamine to midazolam for recurrence of suicidality in adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• Midazolam (Midazolam)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Suicide, Attempted, Suicide and Depression | Phase 3 | Status: COMPLETED